Aug 31, 2022 Flagship Biosciences, Inc., a leader in spatial biology and biomarker analytics services, announced the acquisition of Interpace
YDS Pharmatech helps uncover a novel viral recognition pathway: published in Nature Chemical Biology
Aug 18, 2022 YDS Pharmatech announced the publication of a paper revealing a novel human viral recognition mechanism in Nature Chemical Biology
A Digital Assay to Streamline PD-L1 IHC: Published in Scientific Reports
Jun 14, 2022 Flagship Biosciences, Inc., today announced the publication of a paper describing validation of a novel digital spatial biology
DxTerity Diagnostics Announces the Launch of IFN-1 Test for Lupus
Jun 09, 2022 DxTerity Diagnostics today announced the commercial launch of their IFN-1 Test for patients with Systemic Lupus Erythematosus (SLE
DxTerity Diagnostics Begins Enrollment in the ELEVATE Clinical Study for Lupus
May 27, 2022 LOS ANGELES, May 27, 2022 /PRNewswire/ -- DxTerity Diagnostics today announced the opening of enrollment in ELEVATE
Foresight Diagnostics Expands Scientific Advisory Board with Appointment of Christopher R. Flowers, M.D., M.S.
Apr 27, 2022 Foresight Diagnostics today announced the appointment of Christopher R. Flowers, M.D., M.S., to its Scientific Advisory Board (SAB).
Foresight Diagnostics Announces the Hiring of Sandra Close, Ph.D., as Chief Operations Officer
Apr 04, 2022 Foresight Diagnostics today announced the hiring of Sandra Close, Ph.D., as Chief Operations Officer (COO). Sandra brings extensive